Home

/

Services

/

Spravato Treatment In Timbergrove

Spravato Treatment in Timbergrove, Houston TX

Second and third generations of the same families still live here. That’s not marketing copy — it’s what actually happens in Timbergrove Manor, where homes built for returning veterans in the late 1940s have passed from parents to children to grandchildren, and where the Timbergrove Manor Civic Club has been hosting Ice Cream Socials and National Night Out events for decades. It’s a neighborhood with roots. With a Lorraine Cherry Nature Preserve, trails along White Oak Bayou, and 5K races that turn out the whole community. A place that earns loyalty. Three Houston locations open Monday–Sunday, 5am–9pm.

Spravato Treatment Rebuilds Brains in Timbergrove

Chronic depression doesn’t just cause low mood. It causes measurable structural changes in the brain — specifically, the progressive pruning of dendritic spines in the prefrontal cortex and hippocampus. These are the synaptic connections that underlie emotional regulation, motivation, and the ability to feel genuine engagement with the people and places around you. Conventional antidepressants — SSRIs, SNRIs, and their predecessors — address this by adjusting monoamine levels: more serotonin in the synapse, more norepinephrine, more dopamine. For many people, that’s enough. For roughly one in three, it isn’t. The synaptic loss continues. The antidepressant adjusts a chemical ratio in a compromised system rather than repairing the system itself.

Spravato repairs the system. McLean Hospital’s Dr. Robert Meisner, Medical Director of McLean’s Ketamine Clinic, describes the mechanism directly: esketamine and ketamine cause “a connection, or synapse, between neurons in the brain to develop, a process called synaptogenesis, which can improve mood.” That synaptogenesis — new synaptic connections growing in the prefrontal cortex and hippocampus — is what changes the experience of being in a neighborhood you love but have lost access to. It’s not symptom management. It’s structural repair, beginning within hours of the first dose.

For Timbergrove residents who’ve tried the standard approach and still haven’t broken through, that distinction between adjustment and repair is the entire story. Spravato offers the repair. Catalyst Health & Wellness delivers it.

What is Spravato Therapy?

Spravato (esketamine) received FDA breakthrough therapy designation before its 2019 approval — reflecting the FDA’s assessment that this compound showed early evidence of substantial improvement over existing treatments for a serious condition. The FDA expanded approval in 2020 to include adults with MDD and active suicidal ideation, and in January 2025, approved esketamine as a standalone monotherapy for treatment-resistant depression — the first FDA-approved medication ever cleared to treat TRD without requiring a concurrent oral antidepressant.

Research consistently shows powerful results:

The TRANSFORM-2 trial found Spravato patients were 70% more likely to achieve remission than those receiving antidepressant plus placebo, with statistically significant improvement at 24 hours

McLean Hospital’s Medical Director confirms that synaptogenesis — “a connection, or synapse, between neurons in the brain to develop” — is the leading mechanistic theory for esketamine’s antidepressant effect

The SUSTAIN-1 trial (JAMA Psychiatry) showed hazard ratio of 0.49 for time to relapse in patients maintained on Spravato versus those transitioned to placebo — the maintenance protocol matters

Post-marketing safety data from the REMS database covering March 2019 through January 2024 — across more than 58,000 patients — confirmed no new safety signals, with transient side effects resolving within the monitored post-dose window

What Our Patients Say

“Catalyst Ketamine changed everything. Within two sessions, I felt a lifting of the heavy fog that had consumed me for so long.”


"It was by chance I came across Dr. Ho. I have had 4 infusions of ketamine with him. It has been a wonderful experience. Dr. Ho is very accommodating."


"Dr Ho’s 30 years experience is apparent. He skillfully discusses the entire treatment process and applies the correct dosage to ensure optimal patient comfort."


"Dr. Ho’s empathy and experience make all the difference—this is a place where you truly feel safe. Ketamine therapy might sound intimidating, but it’s backed by science."


"This treatment has literally saved my life. I’ve suffered from depression and anxiety for over a decade." 


"This was a life changing experience for me. Dr. Ho is kind and makes you feel really comfortable- you can tell he cares about his patients."


Take the First Step Toward Healing

Schedule

Mon – Sun: 6am-9pm

Book Appointment

Conditions We Treat with Spravato Therapy Near Timbergrove

Spravato holds FDA approval for two specific clinical indications. At Catalyst Health & Wellness, we offer it for:

Your Spravato Therapy Journey at Catalyst Health & Wellness

Every step of this process is built to be clear, supported, and genuinely manageable for Timbergrove residents with active community lives and demanding schedules.

No cost, no obligation. A clinical team member reviews your full medication history, current situation, and realistic expectations — and gives you a direct, evidence-based assessment of whether Spravato is the appropriate next step. If it isn’t, you’ll hear that clearly.

Most major commercial plans and Medicare cover Spravato for qualifying TRD patients. Prior authorization is nearly universal and requires specific clinical documentation. Our team handles the entire process: benefits verification, documentation preparation, submission, insurer follow-up, and appeals when needed. Coverage is confirmed before any appointment.

We walk through everything in advance: dietary timing (no food for 2 hours before; no liquids for 30 minutes), what to bring, transportation logistics, and medication timing notes. Your first session begins without ambiguity.

Budget two to two-and-a-half hours. Driving is not permitted on treatment days — every session requires a designated driver or rideshare arranged in advance.

You’ll use the nasal spray in a private, purpose-built treatment room under Dr. Ho’s direct clinical supervision — continuous monitoring of vital signs and blood pressure throughout. Reclinable chair, adjustable lighting, warm blankets, noise-cancelling headphones. Dissociation, if it occurs, peaks around 40 minutes post-dose and resolves within two hours. McLean Hospital’s protocol notes that patients are “monitored before, during, and after this treatment” — the same standard our team applies at every Catalyst session.

After monitoring, you leave with your driver. No driving until the morning after a full night’s sleep. Our team follows up between sessions and adjusts the plan based on your response.

Twice weekly in weeks 1–4. Once weekly in weeks 5–8. Then individualized maintenance — weekly, biweekly, or monthly — based on your actual response trajectory. McLean Hospital describes this as generally “every 1–3 weeks” in the maintenance phase, calibrated to individual need. We follow the same personalized approach.

The Science Behind Spravato for Treatment-Resistant Depression

Spravato’s evidence base spans two pivotal phase 3 trials, a 2025 monotherapy study, and nearly six years of post-approval safety data reviewed by regulatory bodies in over 77 countries.

The TRANSFORM-2 study (American Journal of Psychiatry) enrolled TRD patients in a double-blind comparison of flexibly-dosed Spravato plus a newly initiated oral antidepressant versus antidepressant plus placebo. Spravato patients were 70% more likely to achieve remission. Statistically significant improvement was documented at 24 hours — a speed that reflects the synaptogenesis McLean Hospital’s Dr. Meisner describes: new synaptic connections forming in the prefrontal cortex and hippocampus, beginning within hours of NMDA receptor blockade, producing antidepressant effects at a pace that monoamine-based treatment simply cannot achieve.

The SUSTAIN-1 trial (JAMA Psychiatry) established durability: hazard ratio of 0.49 for time to relapse in maintained patients versus those transitioned to placebo (p=0.003). McLean Hospital’s protocol specifically includes a maintenance phase “generally every 1–3 weeks” — the clinical recognition that the synaptogenic gains of induction must be sustained to prevent relapse.

Key research findings:

  • Esketamine causes synaptogenesis — the formation of new synaptic connections in mood-regulating brain regions — a structural repair mechanism that goes beyond chemical adjustment
  • McLean Hospital’s research team, in collaboration with Massachusetts General Hospital, is using AI to determine which patients benefit most from esketamine versus other neurotherapeutic approaches — reflecting the scientific seriousness with which this treatment is now studied
  • ASPIRE I and II trials confirmed significant depressive symptom reduction within 24 hours in patients with MDD and active suicidal ideation — the only FDA-approved rapid pharmacological option for that clinical population
  • January 2025 FDA monotherapy approval expanded the clinical pathway, allowing qualifying patients to use Spravato without a concurrent oral antidepressant

Why Choose Catalyst Health & Wellness for Spravato Treatment Near Timbergrove

01

REMS-Certified Provider

FDA REMS certification is required for every Spravato treatment setting. Catalyst holds full certification at all three Houston locations — and the Heights clinic at 104 W. 12th Street is reachable from Timbergrove Manor in approximately 10 minutes via TC Jester. For twice-weekly treatment during the four-week induction phase, that proximity is a practical advantage that compounds across 8 sessions.

02

Dr. Ho: The Right Credentials for This Medication

Esketamine’s parent compound is an anesthetic. The dosing precision and physiological monitoring it requires — blood pressure tracking, sedation assessment, dissociation monitoring — are anesthesiology skillsets, not standard psychiatric training. Dr. Ho’s board certification in anesthesiology positions him differently than most Spravato providers. He understands the compound’s behavior in the body at a depth that translates to better dosing judgment and more competent monitoring. His former career as a pediatrician means that clinical precision is paired with genuine attentiveness to patient experience.

03

Insurance Navigation

Spravato prior authorization requires specific clinical documentation about prior treatment history. We prepare, submit, and follow up on that documentation entirely — across dozens of commercial insurance plans and Medicare. Coverage is confirmed before any session is scheduled. If a first authorization is denied, we handle the appeal.

04

Whole-Person Approach

McLean Hospital explicitly coordinates esketamine with a patient’s broader treatment picture. Our team does the same. We engage with your existing psychiatric or prescribing provider, understand your full treatment history, and build a treatment plan around your specific situation — not a default protocol. As your response evolves, the plan evolves with it.

05

Extended Hours & Flexible Scheduling

Each session requires two or more hours in clinic. For Lazybrook and Heights-area residents managing jobs, families, and the rhythms of a neighborhood where community involvement matters, the 5am to 9pm hours at all three Houston locations mean treatment doesn’t require sacrificing something else. Pre-dawn appointments, evening sessions, weekends — all available, all week, every week.

06

Comprehensive Treatment Options

Spravato is a powerful tool, but it’s not the only one. When your clinical picture benefits from a multi-modal approach, Catalyst offers complementary evidence-based treatments under the same roof:

Ketamine Therapy

Broader applications including anxiety, PTSD, chronic pain, OCD, and bipolar depression

TMS Therapy

Non-invasive magnetic brain stimulation for depression and OCD

Stellate Ganglion Block

Targeted nerve block treatment for PTSD and anxiety

Our goal is to find the right combination of treatments for your unique situation — not to fit you into a one-size-fits-all protocol.

07

Safe, Comfortable Environment

Our treatment rooms were designed specifically for the Spravato experience — not repurposed from other clinical uses. Each is private, quiet, and carefully arranged: reclinable chairs, soft adjustable lighting, warm blankets, noise-cancelling headphones. Dr. Ho’s clinical team is present and monitoring throughout every session. You’re observed, supported, and never alone.

Getting Started with Spravato Treatment Near Timbergrove

Timbergrove Manor invested in itself — in deed restrictions to protect the aesthetic, in civic clubs to sustain the community, in parks and trails and neighborhood events to keep people connected across decades. That investment in quality of place reflects an understanding that where you live shapes who you can be. The same logic applies to mental health treatment: the right intervention, delivered by the right team, close enough to actually use — that combination shapes what recovery looks like.

Call 800-772-1242 for a free consultation. Our clinical team will review your history, give you an honest assessment, and answer every question without deflection.

The Heights clinic is 10 minutes from Timbergrove via TC Jester. Appointments run 5am to 9pm, every day of the week.

Our Schedule

Monday-Sunday, 6am-9pm

Free consultation

Insurance assistance

Three Houston locations

REMS-certified provider

Commonly Asked Questions

Get Help Now

How quickly does Spravato therapy work?

Many patients notice improvements within hours or days of their first treatment. The TRANSFORM-2 study showed significant improvement compared to placebo within 24 hours. This rapid action is one of Spravato’s most remarkable qualities, especially compared to traditional antidepressants that can take 4 to 8 weeks to work.

Is Spravato therapy safe?

Yes, when administered by trained medical professionals in a REMS-certified setting. Spravato underwent extensive clinical trials before FDA approval. Common side effects like dissociation, dizziness, and temporary blood pressure increases typically resolve within 1-2 hours. We monitor your vital signs throughout treatment to ensure your safety.

How many treatments will I need?

During the first month, you’ll receive Spravato twice weekly. In the second month, treatment typically decreases to once weekly. After that, most patients continue with maintenance treatments once weekly or every two weeks. The exact frequency depends on your individual response. We’ll work with you to find the schedule that keeps you feeling your best.

What does Spravato treatment feel like?

Experiences vary from person to person. Many patients describe feeling relaxed, calm, or somewhat disconnected from their surroundings. Some people experience mild visual or sensory changes. These effects are temporary and typically resolve within 1-2 hours after treatment ends. Most patients find the experience manageable and therapeutic.

Can I drive after a Spravato treatment?

No, you cannot drive yourself home after Spravato treatment, and you should not drive until the next day after a restful night’s sleep. You’ll need to arrange transportation both to and from your appointment. By the time you leave our facility after the 2-hour observation period, you’ll feel much clearer, but driving remains unsafe until the following day.

Will my insurance cover Spravato?

Many insurance plans cover Spravato for qualifying patients since it’s FDA-approved for treatment-resistant depression. Coverage varies by plan and typically requires prior authorization. Our team handles the insurance process for you, including benefits verification and prior authorization submissions.

Can I continue my current medications?

Spravato is always used alongside an oral antidepressant, so you’ll continue taking your prescribed antidepressant medication. We’ll coordinate with your prescribing physician to ensure your overall treatment plan is optimized. Some medications may require adjustment before starting Spravato, which we’ll discuss during your consultation.

Do I need a referral from my doctor?

No, you don’t need a referral to begin Spravato therapy at Catalyst Health & Wellness. However, coordination with your current prescribing physician is important since Spravato must be used alongside an oral antidepressant. We encourage communication between all members of your healthcare team.

Our Locations

Catalyst Health & Wellness Heights

104 W. 12th Street, Suite B Houston, TX 77008

Visit Clinic

Catalyst Health & Wellness Southwest

7710 Beechnut, Suite 206 Houston, TX 77074

Visit Clinic

Catalyst Health & Wellness South Loop

6300 West Loop S Suite 525
Bellaire, TX 77401

Visit Clinic

Make an Appointment

Our mission is to empower individuals to overcome life’s challenges through professional psychological support.

Schedule

Mon – Sun: 6am-9pm